Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Capital/Financing Update 2023

Sep 20, 2023

62616_rns_2023-09-20_9e93eec9-3c28-4159-97f1-f3f99a432fca.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [136 x 45] intentionally omitted <==

September 20, 2023

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051 Scrip code: STAR

Dear Madam/ Sir,

Sub: Intimation of Board Meeting and Investors Call

We refer to Company’s announcement of August 2, 2023 as part of Q1 FY24 Earnings Presentation about our intent to combine CDMO interests of the group to become one of India’s top specialty pharmaceuticals CDMOs.

We now wish to inform you that a board meeting of the Company is scheduled to be held on Monday, September 25, 2023 to consider the above proposal.

The Company will also host a call on Monday, September 25, 2023 at 17:00 hrs IST to interact with the investors in connection with the above proposal.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited,

MANJULA Digitally signed by MANJULA RAMAMURTHY RAMAMURTHY Date: 2023.09.20 20:14:01 +05'30'

Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

==> picture [479 x 53] intentionally omitted <==